Form 8-K - Current report:
SEC Accession No. 0001640334-21-000755
Filing Date
2021-04-02
Accepted
2021-04-01 19:40:06
Documents
2
Period of Report
2021-03-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K clcs_8k.htm 8-K 14151
2 EX-99.1 clcs_ex991.htm EX-99.1 13771
  Complete submission text file 0001640334-21-000755.txt   29246
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

EIN.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55413 | Film No.: 21800091
SIC: 2834 Pharmaceutical Preparations